rs1553614440
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_033337.3(CAV3):c.254C>A(p.Ala85Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A85T) has been classified as Pathogenic.
Frequency
Consequence
NM_033337.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CAV3 | NM_033337.3 | c.254C>A | p.Ala85Asp | missense_variant | Exon 2 of 2 | ENST00000343849.3 | NP_203123.1 | |
| CAV3 | NM_001234.5 | c.254C>A | p.Ala85Asp | missense_variant | Exon 2 of 3 | NP_001225.1 | ||
| OXTR | XR_007095681.1 | n.1885-3063G>T | intron_variant | Intron 4 of 4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CAV3 | ENST00000343849.3 | c.254C>A | p.Ala85Asp | missense_variant | Exon 2 of 2 | 1 | NM_033337.3 | ENSP00000341940.2 | ||
| CAV3 | ENST00000397368.2 | c.254C>A | p.Ala85Asp | missense_variant | Exon 2 of 3 | 1 | ENSP00000380525.2 | |||
| CAV3 | ENST00000472766.1 | n.155+11675C>A | intron_variant | Intron 1 of 2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:1
This sequence change replaces alanine with aspartic acid at codon 85 of the CAV3 protein (p.Ala85Asp). The alanine residue is highly conserved and there is a moderate physicochemical difference between alanine and aspartic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CAV3-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at